Skip to main content
Erschienen in: Lung 1/2011

01.02.2011

Obstructive Airway Disease and Obstructive Sleep Apnea: Effect of Pulmonary Function

verfasst von: Bhavneesh Sharma, Steven Feinsilver, Robert L. Owens, Atul Malhotra, David McSharry, Stephen Karbowitz

Erschienen in: Lung | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

This study sought to determine whether reduced pulmonary function in obstructive airway disease (OAD) is an independent risk factor for obstructive sleep apnea (OSA). This was a prospective observational study conducted at an outpatient pulmonary clinic. Adults with a known diagnosis of COPD/asthma were enrolled as OAD group. Family members without a history of COPD/asthma who accompanied these patients to the clinic were enrolled as a control group. The Berlin Questionnaire (BQ) was used to assess OSA risk in the OAD group and controls. Forced expiratory volume in 1 second (FEV1 % predicted) was determined from spirometry. The subjects at high risk for OSA were referred for a full overnight polysomnogram (PSG). The prevalence of patients with a high risk of OSA was 55.2% in the OAD group, which was higher than in the controls (7.5%, p < 0.0001). OAD subjects had a higher body mass index (BMI) and larger neck circumference than controls (p < 0.01). There was no difference in FEV1 % predicted between the OAD patients at high risk and low risk of OSA. On receiver operator curve (ROC) analysis, FEV1 % predicted was not a significant predictor of high OSA risk. Using logistic regression, FEV1 % predicted had no association with OSA risk. There was no correlation between FEV1 % predicted and total apnea–hypopnea index (AHI), oxygen desaturation index, % time spent below oxygen saturation 90%, and mean oxygen saturation on multiple regression analysis. OSA appears to be common in patients with COPD or asthma in an urban outpatient pulmonary clinic. However, the high prevalence of OSA in OAD patients appears to be due to obesity, and reduced pulmonary function is not an independent risk factor for OSA.
Literatur
1.
Zurück zum Zitat Tishler PV, Larkin EK, Schluchter MD, Redline S (2003) Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA 289:2230–2237CrossRefPubMed Tishler PV, Larkin EK, Schluchter MD, Redline S (2003) Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA 289:2230–2237CrossRefPubMed
2.
Zurück zum Zitat Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165:1217–1239CrossRefPubMed Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165:1217–1239CrossRefPubMed
3.
Zurück zum Zitat Auckley D, Moallem M, Shaman Z, Mustafa M (2008) Findings of a Berlin Questionnaire survey: comparison between patients seen in an asthma clinic versus internal medicine clinic. Sleep Med 9:494–499CrossRefPubMed Auckley D, Moallem M, Shaman Z, Mustafa M (2008) Findings of a Berlin Questionnaire survey: comparison between patients seen in an asthma clinic versus internal medicine clinic. Sleep Med 9:494–499CrossRefPubMed
4.
Zurück zum Zitat Alharbi M, Almutairi A, Alotaibi D, Alotaibi A, Shaikh S, Bahammam AS (2009) The prevalence of asthma in patients with obstructive sleep apnoea. Prim Care Respir J 18:328–330CrossRefPubMed Alharbi M, Almutairi A, Alotaibi D, Alotaibi A, Shaikh S, Bahammam AS (2009) The prevalence of asthma in patients with obstructive sleep apnoea. Prim Care Respir J 18:328–330CrossRefPubMed
5.
Zurück zum Zitat Julien JY, Martin JG, Ernst P, Olivenstein R, Hamid Q, Lemière C, Pepe C, Naor N, Olha A, Kimoff RJ (2009) Prevalence of obstructive sleep apnea–hypopnea in severe versus moderate asthma. J Allergy Clin Immunol 124:371–376CrossRefPubMed Julien JY, Martin JG, Ernst P, Olivenstein R, Hamid Q, Lemière C, Pepe C, Naor N, Olha A, Kimoff RJ (2009) Prevalence of obstructive sleep apnea–hypopnea in severe versus moderate asthma. J Allergy Clin Immunol 124:371–376CrossRefPubMed
6.
Zurück zum Zitat Yigla M, Tov N, Solomonov A, Rubin AH, Harlev D (2003) Difficult-to-control asthma and obstructive sleep apnea. J Asthma 40:865–871CrossRefPubMed Yigla M, Tov N, Solomonov A, Rubin AH, Harlev D (2003) Difficult-to-control asthma and obstructive sleep apnea. J Asthma 40:865–871CrossRefPubMed
7.
Zurück zum Zitat ten Brinke A, Sterk PJ, Masclee AA, Spinhoven P, Schmidt JT, Zwinderman AH, Rabe KF, Bel EH (2005) Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 26:812–818CrossRefPubMed ten Brinke A, Sterk PJ, Masclee AA, Spinhoven P, Schmidt JT, Zwinderman AH, Rabe KF, Bel EH (2005) Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 26:812–818CrossRefPubMed
8.
Zurück zum Zitat Ramagopal M, Scharf SM, Roberts DW, Blaisdell CJ (2008) Obstructive sleep apnea and history of asthma in snoring children. Sleep Breath 12:381–392CrossRefPubMed Ramagopal M, Scharf SM, Roberts DW, Blaisdell CJ (2008) Obstructive sleep apnea and history of asthma in snoring children. Sleep Breath 12:381–392CrossRefPubMed
9.
Zurück zum Zitat Flenley DC (1985) Sleep in chronic obstructive lung disease. Clin Chest Med 6:51–61 Flenley DC (1985) Sleep in chronic obstructive lung disease. Clin Chest Med 6:51–61
10.
Zurück zum Zitat Guilleminault C, Cummiskey J, Motta J (1980) Chronic obstructive airflow disease and sleep studies. Am Rev Respir Dis 122:397–406PubMed Guilleminault C, Cummiskey J, Motta J (1980) Chronic obstructive airflow disease and sleep studies. Am Rev Respir Dis 122:397–406PubMed
11.
Zurück zum Zitat Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R (1995) Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am Rev Respir Dis 151:82–86 Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R (1995) Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am Rev Respir Dis 151:82–86
12.
Zurück zum Zitat Sanders MH, Newman AB, Haggerty CL, for the Sleep Heart Health Study (2003) Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med 167:7–14CrossRefPubMed Sanders MH, Newman AB, Haggerty CL, for the Sleep Heart Health Study (2003) Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med 167:7–14CrossRefPubMed
13.
Zurück zum Zitat Bednarek M, Plywaczewski R, Jonczak L, Zielinski J (2005) There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study. Respiration 72:142–149CrossRefPubMed Bednarek M, Plywaczewski R, Jonczak L, Zielinski J (2005) There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study. Respiration 72:142–149CrossRefPubMed
14.
Zurück zum Zitat Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR (2010) Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 182:325–331CrossRefPubMed Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR (2010) Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 182:325–331CrossRefPubMed
15.
Zurück zum Zitat Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP (1999) Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131:485–491PubMed Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP (1999) Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131:485–491PubMed
16.
Zurück zum Zitat Miller MR, Hankinson J, Brusasco V, ATS/ERS Task Force (2005) Standardisation of spirometry. Eur Respir J 26:319–338CrossRefPubMed Miller MR, Hankinson J, Brusasco V, ATS/ERS Task Force (2005) Standardisation of spirometry. Eur Respir J 26:319–338CrossRefPubMed
17.
Zurück zum Zitat American Academy of Sleep Medicine (2007) AASM Manual for the scoring of sleep and associated events: rules, terminology, and technical specifications. American Academy of Sleep Medicine, Darien, IL American Academy of Sleep Medicine (2007) AASM Manual for the scoring of sleep and associated events: rules, terminology, and technical specifications. American Academy of Sleep Medicine, Darien, IL
18.
Zurück zum Zitat Kinsman RA, Yaroush RA, Fernandez E, Dirks JF, Schocket M, Fukuhara J (1983) Symptoms and experiences in chronic bronchitis and emphysema. Chest 83:755–761CrossRefPubMed Kinsman RA, Yaroush RA, Fernandez E, Dirks JF, Schocket M, Fukuhara J (1983) Symptoms and experiences in chronic bronchitis and emphysema. Chest 83:755–761CrossRefPubMed
20.
Zurück zum Zitat Camargo CA Jr, Weiss ST, Zhang S, Willett WC, Speizer FE (1999) Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med 159:2582–2588CrossRefPubMed Camargo CA Jr, Weiss ST, Zhang S, Willett WC, Speizer FE (1999) Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med 159:2582–2588CrossRefPubMed
21.
Zurück zum Zitat Teodorescu M, Consens FB, Bria WF, Coffey MJ, McMorris MS, Weatherwax KJ, Palmisano J, Senger CM, Ye Y, Kalbfleisch JD, Chervin RD (2009) Predictors of habitual snoring and obstructive sleep apnea risk in patients with asthma. Chest 135:1125–1132CrossRefPubMed Teodorescu M, Consens FB, Bria WF, Coffey MJ, McMorris MS, Weatherwax KJ, Palmisano J, Senger CM, Ye Y, Kalbfleisch JD, Chervin RD (2009) Predictors of habitual snoring and obstructive sleep apnea risk in patients with asthma. Chest 135:1125–1132CrossRefPubMed
22.
Zurück zum Zitat Kimoff RJ, Sforza E, Champagne V, Ofiara L, Gendron D (2001) Upper airway sensation in snoring and obstructive sleep apnea. Am J Respir Crit Care Med 164:250–255PubMed Kimoff RJ, Sforza E, Champagne V, Ofiara L, Gendron D (2001) Upper airway sensation in snoring and obstructive sleep apnea. Am J Respir Crit Care Med 164:250–255PubMed
23.
Zurück zum Zitat Kimoff RJ (2007) Upper airway myopathy is important in the pathophysiology of obstructive sleep apnea. J Clin Sleep Med 3:567–569PubMed Kimoff RJ (2007) Upper airway myopathy is important in the pathophysiology of obstructive sleep apnea. J Clin Sleep Med 3:567–569PubMed
24.
Zurück zum Zitat Hoffstein V, Zamel N, Phillipson EA (1984) Lung volume dependence of pharyngeal cross-sectional area in patients with obstructive sleep apnea. Am Rev Respir Dis 130:175–178PubMed Hoffstein V, Zamel N, Phillipson EA (1984) Lung volume dependence of pharyngeal cross-sectional area in patients with obstructive sleep apnea. Am Rev Respir Dis 130:175–178PubMed
Metadaten
Titel
Obstructive Airway Disease and Obstructive Sleep Apnea: Effect of Pulmonary Function
verfasst von
Bhavneesh Sharma
Steven Feinsilver
Robert L. Owens
Atul Malhotra
David McSharry
Stephen Karbowitz
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
Lung / Ausgabe 1/2011
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-010-9270-3

Weitere Artikel der Ausgabe 1/2011

Lung 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.